Grzeczka A, Graczyk S, Kordowitzki P
Geroscience. 2025; .
PMID: 39865135
DOI: 10.1007/s11357-025-01520-0.
Xia X, Shan H, Jin Z, Ma T, Liu Y, Zhang J
Heliyon. 2025; 11(1):e40653.
PMID: 39811317
PMC: 11729661.
DOI: 10.1016/j.heliyon.2024.e40653.
Yu F, Chen J, Zhang X, Ma Z, Wang J, Wu Q
J Clin Hypertens (Greenwich). 2024; 27(1):e14942.
PMID: 39686847
PMC: 11771816.
DOI: 10.1111/jch.14942.
Beikzadeh B, Khani M, Zarinehzadeh Y, Abedini Bakhshmand E, Sadeghizadeh M, Rabbani S
PLoS One. 2024; 19(10):e0311817.
PMID: 39388499
PMC: 11469592.
DOI: 10.1371/journal.pone.0311817.
Paronetto M, Crescioli C
Front Endocrinol (Lausanne). 2024; 15:1461642.
PMID: 39355618
PMC: 11442314.
DOI: 10.3389/fendo.2024.1461642.
The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism.
Chen Q, Wang W, Xu Q, Dai Y, Zhu X, Chen Z
J Cell Mol Med. 2024; 28(19):e70124.
PMID: 39351650
PMC: 11443162.
DOI: 10.1111/jcmm.70124.
Novel Impact of Colchicine on Interleukin-10 Expression in Acute Myocardial Infarction: An Integrative Approach.
Handari S, Rohman M, Sargowo D, Aulanniam , Nugraha R, Lestari B
J Clin Med. 2024; 13(16).
PMID: 39200761
PMC: 11354751.
DOI: 10.3390/jcm13164619.
Macrophage OTUD1-CARD9 axis drives isoproterenol-induced inflammatory heart remodelling.
Qian J, Wang Q, Xu J, Liang S, Zheng Q, Guo X
Clin Transl Med. 2024; 14(8):e1790.
PMID: 39118286
PMC: 11310286.
DOI: 10.1002/ctm2.1790.
Grand challenges in molecular cardiology.
De Windt L
Front Mol Med. 2024; 2:920039.
PMID: 39086972
PMC: 11285535.
DOI: 10.3389/fmmed.2022.920039.
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development.
Caturano A, Vetrano E, Galiero R, Salvatore T, Docimo G, Epifani R
Rev Cardiovasc Med. 2024; 23(5):165.
PMID: 39077592
PMC: 11273913.
DOI: 10.31083/j.rcm2305165.
Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking.
Zhou M, Li T, Lv S, Gan W, Zhang F, Che Y
Front Immunol. 2024; 15:1351945.
PMID: 38994368
PMC: 11236603.
DOI: 10.3389/fimmu.2024.1351945.
Interleukin-5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II-infused mice.
Shen C, Wu N, Chen X, Peng J, Feng M, Wang J
J Cell Mol Med. 2024; 28(13):e18493.
PMID: 38963241
PMC: 11223166.
DOI: 10.1111/jcmm.18493.
Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy.
Pavelec C, Young A, Luviano H, Orrell E, Szagdaj A, Poudel N
Circ Res. 2024; 135(4):503-517.
PMID: 38957990
PMC: 11293983.
DOI: 10.1161/CIRCRESAHA.124.324650.
Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension.
Zheng X, Zhang C, Yang T, Luo Z, Xia J, Tian W
J Thorac Dis. 2024; 16(5):3152-3169.
PMID: 38883633
PMC: 11170365.
DOI: 10.21037/jtd-23-1822.
Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.
Mallaredy V, Roy R, Cheng Z, Thej C, Benedict C, Truongcao M
Circ Res. 2024; 135(2):280-297.
PMID: 38847080
PMC: 11223950.
DOI: 10.1161/CIRCRESAHA.123.324110.
Non-Classical Effects of FGF23: Molecular and Clinical Features.
Martinez-Heredia L, Canelo-Moreno J, Garcia-Fontana B, Munoz-Torres M
Int J Mol Sci. 2024; 25(9).
PMID: 38732094
PMC: 11084844.
DOI: 10.3390/ijms25094875.
Cardiac hypertrophy that affects hyperthyroidism occurs independently of the NLRP3 inflammasome.
Parletta A, Cerri G, Gasparini C, Panico K, Vieira-Junior D, Zacarias-Rodrigues L
Pflugers Arch. 2024; 476(7):1065-1075.
PMID: 38679646
DOI: 10.1007/s00424-024-02965-6.
The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review.
Zhang L, Xie F, Zhang F, Lu B
Medicine (Baltimore). 2024; 103(17):e37994.
PMID: 38669371
PMC: 11049793.
DOI: 10.1097/MD.0000000000037994.
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review).
Chen B, Guo J, Ye H, Wang X, Feng Y
Mol Med Rep. 2024; 29(5).
PMID: 38488029
PMC: 10955520.
DOI: 10.3892/mmr.2024.13197.
Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis.
Beslika E, Leite-Moreira A, De Windt L, da Costa Martins P
Cardiovasc Res. 2024; 120(5):461-475.
PMID: 38428029
PMC: 11060489.
DOI: 10.1093/cvr/cvae045.